Pharmaceutical giant Pfizer is planning on merging with a counterpart in Ireland called Allergan. Critics are pointing out that if this merger is successful, it could save Pfizer a lot in taxes. Corporations like to base their company in Ireland because of their low corporate tax rate. The merger could cost American tax payers millions. Cenk Uygur and Ana Kasparian (The Point) hosts of The Young Turks discuss. – The Young Turks